US 8563692
Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 8563692 (Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities) held by The Regents of the University of California expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61K38/212, A61K38/215